×
About 83 results

ALLMedicine™ Prostate Cancer Guidelines Center

Research & Reviews  15 results

Recommendations on Weight Loss and Healthy Lifestyle in Prostate Cancer Clinical Guidel...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835487
International Journal of Environmental Research and Publi... Rivera-Izquierdo M, Martínez-Ruiz V et. al.

Feb 16th, 2022 - Obesity is associated with negative prostate cancer outcomes (e.g., specific mortality, all-cause mortality, biochemical recurrence, etc.), according to the current scientific literature. Nevertheless, recommendations on weight loss and healthy li...

MR Image Guided Therapy in Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT01377753

Feb 1st, 2022 - Background: Pilot study is designed to evaluate the safety and feasibility of thermal laser ablation of focal prostate tumors. Prostate cancer is relatively slow growing, with doubling times for local tumors estimated at 2 to 4 years. Some prostat...

Re: NCCN Prostate Cancer Guidelines Version 1.2022 - September 10, 2021.
https://doi.org/10.1016/j.eururo.2021.11.025
European Urology; Grummet J, Eggener S

Dec 14th, 2021 - Re: NCCN Prostate Cancer Guidelines Version 1.2022 - September 10, 2021.|2021|Grummet J,Eggener S,|diagnosis,therapy,

PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urolo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717195
Journal of Nuclear Medicine : Official Publication, Socie... Ferdinandus J, Fendler WP et. al.

Oct 9th, 2021 - The European Association of Urology (EAU) prostate cancer guidelines panel recommends risk groups for biochemical recurrence (BCR) of prostate cancer to identify men at high risk of progression or metastatic disease. The rapidly growing availabili...

Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy fo...
https://doi.org/10.1016/j.eururo.2021.07.024
European Urology; Van Poppel H, Roobol MJ et. al.

Aug 20th, 2021 - Recommendations against prostate-specific antigen (PSA) testing in 2012 have increased advanced-stage diagnosis and prostate cancer-specific mortality rates. To present the position of the European Association of Urology (EAU) in 2021 and provide ...

see more →

Guidelines  1 results

ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but...
https://doi.org/10.1016/j.prro.2020.10.002
Practical Radiation Oncology; Zietman AL,

Dec 15th, 2020 - ASTRO Editorial: The AUA-ASTRO-SUO Advanced Prostate Cancer Guidelines: A Continued but Changing Role for the Radiation Oncologist.|2020|Zietman AL, ,|radiotherapy,

see more →

Clinicaltrials.gov  1 results

MR Image Guided Therapy in Prostate Cancer
https://clinicaltrials.gov/ct2/show/NCT01377753

Feb 1st, 2022 - Background: Pilot study is designed to evaluate the safety and feasibility of thermal laser ablation of focal prostate tumors. Prostate cancer is relatively slow growing, with doubling times for local tumors estimated at 2 to 4 years. Some prostat...

see more →

News  16 results

Prostate Cancer Guidelines Lack Molecular Test Recommendations
https://www.onclive.com/view/prostate-cancer-guidelines-lack-molecular-test-recommendations

Oct 6th, 2021 - Daniel Lin, MD When compared with the National Comprehensive Cancer Network (NCCN) breast cancer guidelines, the corresponding prostate cancer guidelines fall short in one distinct characteristic—the lack of a molecular test in tissue-based platf...

NCCN Guidelines Embrace PSMA-PET Imaging for Prostate Cancer
https://www.medscape.com/viewarticle/959838

Sep 28th, 2021 - Rarely has a footnote garnered so much positive attention, but a reference in the newly updated prostate cancer guidelines from the National Comprehensive Cancer Network (NCCN) has prostate cancer specialists excited about the prospects for incorp...

NCCN and AUA Prostate Cancer Guidelines
https://www.onclive.com/view/nccn-and-aua-prostate-cancer-guidelines

Apr 2nd, 2021 - For High-Definition, Click The NCCN guidelines represent a consensus statement that is compiled using data from a variety of clinical trials, notes Michael E. Williams, MD. The highest level of evidence, labeled category 1, is provided by multi-...

Priority Review Designation in Cervical Cancer, ODAC Recommendation in ALL, and More
https://www.onclive.com/view/priority-review-designation-in-cervical-cancer-odac-recommendation-in-all-and-more

Apr 2nd, 2021 - Today- A priority review designation in cervical cancer, an ODAC recommendation in acute lymphoblastic leukemia, a clinical hold in cervical and head and neck cancer, and an addition to the NCCN Prostate Cancer Guidelines. Welcome to OncLive...

Dr. Gomella on AUA's New Prostate Cancer Guidelines
https://www.onclive.com/view/dr-gomella-on-auas-new-prostate-cancer-guidelines

Dec 20th, 2020 - Leonard G. Gomella, MD, professor and chair of the Department of Urology at the Thomas Jefferson University Hospital Kimmel Cancer Center, discusses the clinical guidelines released by the American Urological Association (AUA) at its 2013 Annual M...

see more →